Australia - English - Department of Health (Therapeutic Goods Administration)

nature's care manufacture pty limited - evening primrose oil, quantity: 1000 mg (equivalent: gamma-linolenic acid, qty 100 mg) - capsule, soft - excipient ingredients: purified water; d-alpha-tocopherol; gelatin; glycerol - maintain/support general health and wellbeing ; maintain/support female healthy hormonal balance ; decrease/reduce/relieve symptoms of premenstrual tension ; decrease/reduce/relieve symptoms of mild eczema/dermatitis ; maintain/support skin health

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

akzo nobel pty limited - cuprous oxide; zinc pyrithione; liquid hydrocarbon - paint - cuprous oxide mineral-copper active 660.0 g/l; zinc pyrithione mineral-zinc active 64.0 g/l; liquid hydrocarbon solvent other 515.0 g/l - antifouling - boat hull (refer to label) - marine growth | barnacles | fresh-water fouling organisms | marine fouling organisms | mussels

Israel - English - Ministry of Health

dexcel ltd, israel - ranitidine as hydrochloride - tablets - ranitidine as hydrochloride 150 mg - ranitidine - ranitidine - adults:zaridex is indicated for the treatment of duodenal ulcer and benign gastric ulcer, including that associated with non-steroidal anti-inflammatory agents. zaridex is also indicated for the treatment of post-operative ulcer, zollinger-ellison syndrome and oesophageal reflux disease including long term management of healed oesophagitis. zaridex is indicated for the following conditions where reduction of gastric secretion and acid output is desirable; the prophylaxis of gastro-intestinal haemorrhage from stress ulceration in seriously ill patients and before general anaesthesia in patients considered to be at risk of acid aspiration (mendelson's syndrome), particularly obstetric patients during labour. children (6 to 18 years):short term treatment of peptic ulcer. treatment of gastro-oesophageal reflux, including reflux oesophagitis and symptomatic relief of gastro-oesophageal reflux disease.

Israel - English - Ministry of Health

dexcel ltd, israel - ranitidine as hydrochloride - caplets - ranitidine as hydrochloride 300 mg - ranitidine - ranitidine - adults:zaridex is indicated for the treatment of duodenal ulcer and benign gastric ulcer, including that associated with non-steroidal anti-inflammatory agents. zaridex is also indicated for the treatment of post-operative ulcer, zollinger-ellison syndrome and oesophageal reflux disease including long term management of healed oesophagitis. zaridex is indicated for the following conditions where reduction of gastric secretion and acid output is desirable; the prophylaxis of gastro-intestinal haemorrhage from stress ulceration in seriously ill patients and before general anaesthesia in patients considered to be at risk of acid aspiration (mendelson's syndrome), particularly obstetric patients during labour. children (6 to 18 years):short term treatment of peptic ulcer. treatment of gastro-oesophageal reflux, including reflux oesophagitis and symptomatic relief of gastro-oesophageal reflux disease.

Israel - English - Ministry of Health

dexcel ltd, israel - omeprazole - caplets - omeprazole 20 mg - omeprazole - omeprazole - relief of reflux-like symptoms (e.g. heartburn) with frequency of two or more days a week in sufferers aged 18 and over.

Israel - English - Ministry of Health

dexcel pharma technologies ltd - clopidogrel as besylate - film coated tablets - clopidogrel as besylate 75 mg - clopidogrel - clopidogrel - secondary prevention of atherotrombotic eventsclopidogrel is indicated in:• adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.• adult patients suffering from acute coronary syndrome - non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave myocardial infarction (mi)), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy.prevention of atherothrobmotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for the treatment with vitamin k antagonists (vka) anti-thrombin or anti factor xa, and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke.

Israel - English - Ministry of Health

dexcel ltd, israel - acetylsalicylic acid - tablets enteric coated - acetylsalicylic acid 75 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.

Israel - English - Ministry of Health

dexcel ltd, israel - acetylsalicylic acid - tablets enteric coated - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.

Israel - English - Ministry of Health

dexcel ltd, israel - carvedilol - tablets - carvedilol 6.25 mg - carvedilol - carvedilol - treatment of symptomatic congestive heart failure. carvedexxon may be used as adjunct to standard therapy, but may also be used in those patients unable to tolerate an ace inhibitor, or those who are not receiving digitalis, hydralazine or nitrate therapy.

Israel - English - Ministry of Health

dexcel ltd, israel - carvedilol - tablets - carvedilol 12.5 mg - carvedilol - carvedilol - treatment of symptomatic congestive heart failure. carvedexxon may be used as adjunct to standard therapy, but may also be used in those patients unable to tolerate an ace inhibitor, or those who are not receiving digitalis, hydralazine or nitrate therapy.